LOGAN VANSICKLE: Open Payments
NPI 1699335968 · HENDERSON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,180 in 91 payments from 11 companies in 2025. Trend: 2023 $1,126 · 2024 $1,358 · 2025 $1,180
Food & beverage: $1,180
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 47 | $506 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 24 | $332 |
| Axsome Therapeutics, Inc. | 4 | $92 |
| Vanda Pharmaceuticals Inc. | 5 | $88 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Phathom Pharmaceuticals, Inc. | 4 | $26 |
| Novo Nordisk Inc | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: CAPLYTA, QULIPTA, UBRELVY, VRAYLAR, Auvelity, HETLIOZ, FANAPT, AIRSUPRA.
Industry payments across KY — which companies pay providers there.
